| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.093 | 0.02 |
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.099 | 0.02 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.14 | 0.02 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.087 | 0.02 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.02 |
| mRNA | GSK429286A | GDSC1000 | pan-cancer | AAC | -0.079 | 0.02 |
| mRNA | CHEMBL374350 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | pifithrin-mu | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.02 |